Abstract:OBJECTIVE:To study whether the expression level of cyclooxygenase-2 (COX-2) is correlated with the proliferation and apoptosis of cancer cells and to study whether the RNA interference technique can be used in anti-cancer gene therapy.METHODS:WBH1, a eukaryotic expression plasmid of shRNA targeting on COX-2, was constructed. Human gastric cancer cells of the line SGC-7901 were cultured and divided into 3 groups: to be transfected with WBH1 or negative control plasmid HK, or used as un-transfected control group. RT-PCR and Western blotting were used to detect the expression of COX-2 mRNA and protein. MTT method was used to detect the proliferation of the cells. The apoptosis of the cells was determined by flow cytometry. Fifteen nude mice were randomly divided into 3 equal groups: 10 to be inoculated subcutaneously with WBH1 plasmid transfected SGC-7901 cells (inhibition group) or negative control plasmid HK transfected SGC-7901 cells, and 5 were used as un-transfected controls. The mice were observed for 4 weeks to observe the survival and the tumorigenesis. Then the mice were killed to take out the tumors. The tumorigenic rate and tumor inhibition rate were evaluated.RESULTS:The proliferation of the SGC-7091 cells transfected with WHB1 plasmid did not changed significantly 24 and 48 hours after the transfection, however, decreased significantly 96 hours and 1 week after (both P < 0.01). The apoptotic rate of the SGC-7091 cells transfected with WHB1 plasmid was 52.28% +/- 17.91%, significantly higher than that of the cells transfected with the control plasmid HK (0.54% +/- 0.16%) and that of the un-transfected cells (0.52% +/- 0.27%, both P = 0.009) without a significant difference between the latter 2 groups (P = 0.998). Four weeks after inoculation the tumorigenic rate was 100% in both the un-transfected control mice and the mice inoculated with negative plasmid HK transfected SGC-7901 cells. There was no significant difference in tumor size between these 2 groups (P = 0.965). The tumorigenic rate of the mice in the inhibition group was 0.4 with an inhibition rate of 89.8%. The tumor weight of the inhibition group was 0.050 g +/- 0.003 g, significantly lighter than those of the control group and the group inoculated with negative plasmid transfected SGC cells (0.490 g +/- 0.017 g and 0.490 g +/- 0.013 g respectively, both P < 0.01).CONCLUSION:Construction of a eukaryotic expression vector expressing the specific shRNA targeting on COX-2, closely related to the proliferation and apoptosis of tumor cells, and transfection of it into the tumor cells helps inhibit the expression of COX-1, thus inhibiting the growth and proliferation of the tumor cells.

COX-2 gene silencing suppresses tumor formation of human gastric cancer cell lines SGC-7901 in nude mice

Inhibition of human gastric cancer metastasis by cox-2 inhibitor

Study on effect of cox-2 inhibitor on proliferation and invasion of human gastric cancer cells

[Effects of Inhibition of Cyclooxygenase-2 by RNA Interference on Proliferation and Apoptosis of Human Gastric Cancer Cells: an Experimental Study with Human Gastric Cancer Cells and Mice].

[Effect of siRNA for mutant p53 gene on biological behavior of gastric cancer cell line SGC7901].

Effects of Silencing Cyclooxygenase-2 Expression Via RNA Interference on the Tumorigenicity of the SMMC-7721 Human Hepatocarcinoma Cell Line.

COX-2 targeted RNA interference inhibits growth of gastric carcinoma cells and induced changes of related signal molecules

Inhibitory effect of siRNA targeting COX-2 on the growth of gastric carcinoma cells of well, moderate or poor differentiation and its mechanism

Silencing Human COX-2 Gene by Construction of Eukaryotic Expression Vector Expressing the Short Hairpin RNA

Inhibitory Effects of Cyclooxygenase-2 Inhibited by Shrna on the Growth and Angiogenesis of Human Liver Cancer Cell Subcutaneous Xenograft Tumors in Nude Mice

Targeted inhibition of COX-2 expression by RNA interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells.

Promotive effect of cyclooxygenase-2 gene inhibited by shRNA on the tumor cells apoptosis of subcutaneous xenograft human liver cancers in nude mice

[Antisense Inhibition of Cyclooxygenase-2 Reduces Malignant Phenotype of Gastric Cancer Cells].

Effects of COX-2 Gene Expression Inhibited by Shrna on Growth of Hepatocellular Carcinoma HepG_2 Cells

The function and mechanism of COX-2 in angiogenesis of gastric cancer cells

Knockdown of Cyclooxygenase-2 Leads to Growth Inhibition and Cell Cycle Arrest in Hepatocellular Carcinoma Cells.

Inhibition of AKT Phosphorylation by COX-2 siRNA in AGS Gastric Cancer Cells

Effects of Cyclooxygenase-2 SiRNA-mediated Gene Silencing on Proliferation and Apoptosis of Human Colon Cancer Cells

Silencing of cyclooxygenase-2 inhibits the growth, invasion and migration of ovarian cancer cells.

Inhibitory Effects of Adenovirus Mediated Cox-2, Akt1 and Pik3r1 Shrna on the Growth of Malignant Tumor Cells in Vitro and in Vivo

[Construction of recombinant adenovirus vector expressing shRNAs targeting COX-2, AKT1 and PIK3R1 gene and its inhibition effect on proliferation of human gastric adenocarcinoma].